U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354126) titled 'Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine' on Jan. 12.
Brief Summary: Flunarizine and propranolol have demonstrated efficacy in reducing migraine frequency across age groups, though evidence in pediatric populations remains limited and inconsistent. Therefore, the current study has been planned to evaluate and compare the effectiveness of flunarizine and propranolol in reducing migraine frequency in children aged 8-15 using the Pediatric Migraine Disability Assessment Scale (PedMIDAS) score.
Study Start Date: Sept. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Migraine
Intervention:
DRUG: Flunar...